These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 15325674
1. Secretory breast carcinoma--case report and review of the medical literature. Costa NM, Rodrigues H, Pereira H, Pardal F, Matos E. Breast; 2004 Aug; 13(4):353-5. PubMed ID: 15325674 [Abstract] [Full Text] [Related]
3. [A case of locally advanced breast cancer successfully treated with FEC (100) followed by weekly paclitaxel]. Tokunaga Y, Takahashi K, Saito T. Gan To Kagaku Ryoho; 2005 Sep; 32(9):1307-9. PubMed ID: 16184929 [Abstract] [Full Text] [Related]
4. Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial. Kerbrat P, Roché H, Bonneterre J, Veyret C, Lortholary A, Monnier A, Fumoleau P, Fargeot P, Namer M, Chollet P, Goudier MJ, Audhuy B, Simon H, Montcuquet P, Eymard JC, Walter S, Clavère P, Guastalla JP, French adjuvant Study Group. Br J Cancer; 2007 Jun 04; 96(11):1633-8. PubMed ID: 17505516 [Abstract] [Full Text] [Related]
5. [Clinical analysis of resectable breast cancer: a report of 6 263 cases]. Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X, Tang J. Ai Zheng; 2005 Mar 04; 24(3):327-31. PubMed ID: 15757535 [Abstract] [Full Text] [Related]
6. Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial. Veyret C, Levy C, Chollet P, Merrouche Y, Roche H, Kerbrat P, Fumoleau P, Fargeot P, Clavere P, Chevallier B. Cancer; 2006 Dec 01; 107(11):2535-44. PubMed ID: 17054108 [Abstract] [Full Text] [Related]
7. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer. Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM, GEICAM 9906 Study Investigators. J Natl Cancer Inst; 2008 Jun 04; 100(11):805-14. PubMed ID: 18505968 [Abstract] [Full Text] [Related]
8. Breast cancer in young women: case report and a review. Batori M, Ruggieri M, Chatelou E, Straniero A, Mariotta G, Palombi L, Casella G, Basile M, Casella MC. Eur Rev Med Pharmacol Sci; 2006 Jun 04; 10(2):51-2. PubMed ID: 16705948 [Abstract] [Full Text] [Related]
9. [Ablative hormone therapy and chemotherapy of metastatic breast cancer]. Kasch R, Gerber B, Blaschke U. Zentralbl Gynakol; 1989 Jun 04; 111(23):1584-7. PubMed ID: 2560303 [Abstract] [Full Text] [Related]
10. [Effective treatment strategy in elderly breast cancer patients]. Boér K. Orv Hetil; 2005 Jan 02; 146(1):15-21. PubMed ID: 15715368 [Abstract] [Full Text] [Related]
11. Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes. Battelli N, Massacesi C, Braconi C, Pilone A, Manzione L, Dinota A, Cobelli S, Scanni A, Sturba F, Giacomini G, Morale D, Giorgi F, Tummarello D, Cascinu S. Am J Clin Oncol; 2006 Aug 02; 29(4):380-4. PubMed ID: 16891866 [Abstract] [Full Text] [Related]
12. A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer. Arcangeli G, Pinnarò P, Rambone R, Giannarelli D, Benassi M. Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):161-7. PubMed ID: 16226397 [Abstract] [Full Text] [Related]
13. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer. Kuru B, Camlibel M, Dinc S, Gulcelik MA, Atalay C, Alagol H. J Exp Clin Cancer Res; 2005 Sep 01; 24(3):363-72. PubMed ID: 16270522 [Abstract] [Full Text] [Related]
14. Surgical management of inflammatory breast cancer. Singletary SE. Semin Oncol; 2008 Feb 01; 35(1):72-7. PubMed ID: 18308148 [Abstract] [Full Text] [Related]
15. Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial. Bonneterre J, Roché H, Kerbrat P, Brémond A, Fumoleau P, Namer M, Goudier MJ, Schraub S, Fargeot P, Chapelle-Marcillac I. J Clin Oncol; 2005 Apr 20; 23(12):2686-93. PubMed ID: 15837983 [Abstract] [Full Text] [Related]
16. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy. Keam B, Im SA, Kim HJ, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Cho N, Moon WK, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ. Breast Cancer Res Treat; 2009 Jul 20; 116(1):153-60. PubMed ID: 18787948 [Abstract] [Full Text] [Related]
18. [The application of conservative surgery for local advanced and bigger primary breast carcinoma]. Li JF, Ouyang T, Wang TF, Xie YT, Lin BY. Zhonghua Wai Ke Za Zhi; 2005 Aug 01; 43(15):1008-10. PubMed ID: 16194361 [Abstract] [Full Text] [Related]
19. Lipid secreting breast carcinoma in childhood: a case report. Balik E, Taneli C, Cetinkursun S, Yazici M, Cetingül N, Erhan Y, Haydaroğlu A, Oztop S. Eur J Pediatr Surg; 1993 Feb 01; 3(1):48-9. PubMed ID: 8466877 [Abstract] [Full Text] [Related]
20. [A case regarded as an occult breast cancer treated without mastectomy]. Kawashima T, Miyazawa Y, Sakata H, Matsubara H, Ryu M, Ochiai T. Gan To Kagaku Ryoho; 2005 Jun 01; 32(6):825-8. PubMed ID: 15984524 [Abstract] [Full Text] [Related] Page: [Next] [New Search]